Aaron Krasner MDDr. Krasner has teamed up with Dr. Fenia Weiller to provide a novel, evidence-informed psychedelic consulting approach to the treatment of treatment-refractory psychiatric conditions.
Psychiatric illnesses are often life long problems and their more severe presentations remain treatment-refractory. Most psychiatric treatments, even partially effective ones, naturally stall out and result in frustrations for therapists and patients alike. The neurobiology of behavior and change supports both of these commonplace findings: the brain as the organ of the mind is redundantly designed and slow to change. While high quality conventional psychiatric treatments remain the standard of care, the era of personalized medicine and interventional psychiatry ushers us into a new generation and paradigm of psychiatry.
We have found that a common final pathway for all successful psychiatric interventions is newness – new neuronal connections, synaptogenesis, and clinically, the capacity to look at familiar problems with beginner’s eyes. We offer adjunctive psychedelic treatment consultations to patients that are engaged in treatment, but not making the kind of progress they, or their therapists, seek. By adding time limited, focused ketamine-assisted psychotherapy to the framework of existing treatments, patients will have a chance to reinvigorate partially effective treatments with novel therapeutic experiences – heralded both by a fascinating molecule (ketamine) and the salutary trance experience. An often-invoked question about the efficacy of psychedelic treatments – is it the trip or the molecule? – will be addressed by our team’s careful attention to both.
The values that form the foundation of this program are safety, creativity, professionalism, collaboration, and positive growth.
For more information about our innovative program and to learn about ketamine, contact our office:
admin@aaronkrasner.com
203-762-6442